Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals.
We are delighted to share our new paper:
Challenges in management of pediatric chronic myeloid leukemia (pCML) in the low- and middle income countries (LMICs’): Insights from an International CML Foundation (iCMLf) Multi National Study
Roy Moulik N et al. Pediatr Hematol Oncol, January 2024 (epub ahead of print)
The survey sheds light on patient, physician, and infrastructure challenges, urging the need for context-specific guidelines, advocacy for continuous TKI access, and improvements in diagnostic resources.
Other latest publications include:
- Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia
Behrens YL et al. Haematologica, March 2024 – open access publication - Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: Influence of demographic, pharmacological, and genetic factors in the German CML-PAED Cohort
Stiehler S et al. Haematologica, March 2024 (epub ahead of print) – open access publication
- Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patient with chronic myeloid leukemia
Abdallah AM et al. Leuk Lymphoma, March 2024 (epub ahead of print) - Chronic spontaneous urticarial as the presenting factor in a paediatric case of chronic myeloid leukemia
Sutton KM et al. Pediatr Blood Cancer, March 2024 - Bosutinib in resistant and intolerant pediatric patients with chronic phase chronic myeloid leukemia: Results from the Phase I part of Study ITCC054/COG AMML1921
Brivio E et al. J Clin Oncol, March 2024 – open access publication - A 3-year old with chronic myeloid leukemia
Coty-Fatall Z & Richardson A. Blood, February 2024 - Reduced-intensity therapy for relapsed Philadelphina chromosome-positive leukemia
Nagasawa S et al. Pediatr Blood Cancer, February 2024 - Pediatric chronic myeloid leukemia P190 variant with IgA vasculitis: Rare association – case report
Shah K et al. Pediatr Blood Cancer, January 2024 - Bosutinib: Pediatric first approval - Review
Hoy SM. Paediatr Drugs, December 2023 (epub ahead of print) - Skin reactions to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia - Review
Toker M et al. Pediatr Dermatol, December 2023 (epub ahead of print) - Treatment and follow-up of children with chronic myeloid leukemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era – Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort
Roy Moulik N et al. Br J Haematol, December 2023 (epub ahead of print)
Search here for more publications on pediatric CML